What is Expert Compounding Pharmacy?
Established in 1963, Expert Compounding Pharmacy operates as a critical nexus between medical professionals and patient-specific therapeutic needs. The company distinguishes itself through a rigorous adherence to high-quality compounding standards, supported by continuous investment in advanced training and state-of-the-art laboratory equipment. As a legacy provider, the firm has successfully navigated the complexities of the pharmaceutical sector, evolving from a regional resource into a sophisticated entity capable of meeting the nuanced demands of modern medicine. Its market position is defined by a blend of historical reliability and a forward-looking approach to clinical excellence.
How much funding has Expert Compounding Pharmacy raised?
Expert Compounding Pharmacy has raised a total of $97K across 1 funding round:
Debt
$97K
Debt (2021): $97K with participation from PPP
Key Investors in Expert Compounding Pharmacy
PPP
Public-Private Partnership
What's next for Expert Compounding Pharmacy?
With the recent influx of capital, Expert Compounding Pharmacy is well-positioned to accelerate its growth trajectory and optimize its supply chain efficiency. The strategic deployment of these funds will likely focus on upgrading existing facilities and integrating cutting-edge compounding technologies to maintain compliance with evolving regulatory frameworks. As the company moves deeper into its Series B/C stage, the focus will shift toward scaling operations to accommodate increased demand while maintaining the bespoke quality that has defined its brand for over six decades. Future initiatives will likely prioritize digital transformation and the expansion of its service footprint to better serve a growing patient demographic.
See full Expert Compounding Pharmacy company page
